Telcon RF Pharmaceutical’s Abion stake holds at 18.19% after share consolidation disclosure
Telcon RF Pharmaceutical reported a change in its Abion stake due to a 5-to-1 share consolidation dated Sept. 14, 2026. Holdings fell to 3,279,220 common shares from 16,396,104, while the common-share stake stayed at 18.19%. Total “specific securities” dropped to 3,410,582 from 17,052,918, with ownership unchanged at 1